Skip to main content
. 2016 Nov 4;7(52):87479–87484. doi: 10.18632/oncotarget.13114

Figure 6.

Figure 6

PET/CT (A) and CT with contrast (B) in follow-up care showing liver lesions disappeared after erlotinib therapy and achieved CR.